Pharma Marketing Blog represents the opinions of
John Mack
Publisher of
Pharma Marketing News.
We accept advertising relevant to the interests of our members.
For more information, see:
Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
My Humble Opinion
|
Other People's Opinion
|
| A "Must Read" Blog for Insiders. -- Wall Street Journal | A bi-weekly podcast. Listen and call-in live online or download to your iPod! |
| Also see Pharma Marketing News OpEd Pieces |
Is Pfizer Arrogant and Superior?Posted: December 7, 2006One repercussion of the torcetrapib failure is the negative publicity Pfizer is receiving and criticisms from Wall Street analysts. Some of the latter may be driven by short-sellers, but some people in the industry seem to have pent-up feelings such as that described by a member of the Pharma Marketing Online Discussion Board: namely, Pfizer is "Arrogant and Superior." What do you think? To vote on this anonymously and read the discussion thread on this subject, plus my own feelings on the subject, see today's post to Pharma Marketing Blog. Can't wait? Take the poll now: For more posts in related topic areas, see: If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.
|
Special Supplement Physician Education Key Opinion Leaders, Medical Science Liaisons, & CME
More than ever, it is important to educate physicians about new drugs and to keep this education separate from the marketing function of the company yet aligned with commercial goals.
This Special Supplement to Pharma Markeing News is critical reading for pharmaceutical companies and physician education service providers wishing to understand the new roles of key opinion leader physicians (KOLs) and medical science liaisons (MSLs) in the physician education process. Order and pay for this Special Supplement now using your credit card. ONLY $29.95
If you wish to pay by check or credit card off-line, please use: |